New NSAID for eyes

Pharmacy Daily - - NEWS -

NPS' Aus­tralian Pre­scriber has pro­vided a brief sum­mary of the role of newly ap­proved Ilevro (nepafenac), by No­var­tis, for pre­ven­tion and treat­ment of pain and in­flam­ma­tion associated with cataract surgery.

Af­ter ad­min­is­tra­tion, nepafenac pen­e­trates the cornea and is rapidly metabolised to am­fenac by hy­dro­lases, the ar­ti­cle ex­plains.

Nepafenac and am­fenac work by po­tently in­hibit­ing cy­clo-oxy­ge­nase (COX) 1 and 2 en­zymes.

Dos­ing is one drop per day for 15 days start­ing the day prior to surgery - go to nps.org.au for more.

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.